Atorvastatin Tied to Cardioprotection for Lymphoma Patients on Anthracyclines
(MedPage Today) -- NEW ORLEANS -- Patients with lymphoma on anthracycline-based chemotherapy who took atorvastatin (Lipitor) for a year were less likely to experience cardiac dysfunction, according to the STOP-CA trial.
The trial's primary endpoint...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Atorvastatin Calcium | Cardiology | Cardiovascular | Chemotherapy | Heart | Lipitor | Lymphoma | Statin Therapy | Zivast